Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Paramount Bed Holdings Co's share price is 円3515.00.
Paramount Bed Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 was 円840.51. Hence, Paramount Bed Holdings Co's PS Ratio for today is 4.18.
Warning Sign:
Paramount Bed Holdings Co Ltd stock PS Ratio (=4.18) is close to 10-year high of 4.34.
The historical rank and industry rank for Paramount Bed Holdings Co's PS Ratio or its related term are showing as below:
TSE:7817'
s PS Ratio Range Over the Past 10 Years
Min: 1.22 Med: 1.58 Max: 4.34
Current: 4.18
During the past 13 years, Paramount Bed Holdings Co's highest PS Ratio was 4.34. The lowest was 1.22. And the median was 1.58.
TSE:7817's PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.85
vs TSE:7817: 4.18
Paramount Bed Holdings Co Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Paramount Bed Holdings Co was -29.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 6.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 5.40% per year.
During the past 13 years, Paramount Bed Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 13.40% per year. The lowest was -7.90% per year. And the median was 6.10% per year.
Back to Basics: PS Ratio
Paramount Bed Holdings Co (TSE:7817) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Paramount Bed Holdings Co PS Ratio Related Terms
Paramount Bed Holdings Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Paramount Bed Holdings Co's Share Price of today is 円3515.00. Paramount Bed Holdings Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円840.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Paramount Bed Holdings Co (TSE:7817) has a PS Ratio of 4.18 as of Jul. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Paramount Bed Holdings Co and its competitors. This is 165% above median its historical median of 1.58. Over the past decade, Paramount Bed Holdings Co's PS Ratio has ranged from 1.22 to 4.34.
Is Paramount Bed Holdings Co's PS Ratio too high?
Paramount Bed Holdings Co's current PS Ratio of 4.18 is 165% above median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 4.34. The Medical Devices & Instruments industry median PS Ratio is 2.85. Paramount Bed Holdings Co's value of 4.18 is 46.7% above this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's PS Ratio compare to ISRG and BDX?
Paramount Bed Holdings Co's PS Ratio of 4.18 can be compared against companies in the Medical Devices & Instruments industry. The industry median PS Ratio is 2.85. Paramount Bed Holdings Co's value of 4.18 is 46.7% above this benchmark. Historically, Paramount Bed Holdings Co's own PS Ratio has ranged from 1.22 to 4.34 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 2.85, Paramount Bed Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.85, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current PS Ratio of 4.18 is 46.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Paramount Bed Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current PS Ratio is 4.18, which is 165% above median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (TSE:7817) has a current PS Ratio of 4.18. The stock's GF Value™ is 円2,907.43, compared to a current price of 円3,515.00 — trading 20.9% above its estimated fair value. The current PS Ratio is 4.18, which is 165% above median its 10-year median of 1.58 and 46.7% above the Medical Devices & Instruments industry median of 2.85. Paramount Bed Holdings Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Paramount Bed Holdings Co (TSE:7817), the current PS Ratio is 4.18 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (TSE:7817) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of 円3,515.00 is trading 20.9% above its estimated GF Value™ of 円2,907.43.
Key valuation signals for TSE:7817:
PS Ratio: 4.18 (165% above median its 10-year median of 1.58)
GF Value™: 円2,907.43 vs. price of 円3,515.00 (20.9% above fair value)
Industry Position: 46.7% above the Medical Devices & Instruments median
No single metric tells the full story. See the TSE:7817 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
69GF Score
Get the complete analysis for TSE:7817
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7817 has been successfully added to your 
